Efficacy and Safety of Ginkgo Biloba Extract in Mild Cognitive Impairment and Cerebrovascular Insufficiency

NCT00446485 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

90

Enrollment

OTHER

Sponsor class

Conditions

Mild Cognitive Impairment
Cerebrovascular Insufficiency

Interventions

DRUG: Ginkgo biloba standardized extract 24/6
DRUG: Ginkgo Biloba standardized extract 24/6
DRUG: placebo

Sponsor

Milsing d.o.o.